Načítá se...
Secondary and tertiary ovarian cancer recurrence: what is the best management?
Ovarian cancer with complete clinical response recurs with a high rate. Recurrence is observed in almost 25% of cases with early-stage diseases and in more than 80% with more advance stages. Based on a platinum-free interval cut-off of 6 months, the first recurrence is usually classified in platinum...
Uloženo v:
| Vydáno v: | Gland Surg |
|---|---|
| Hlavní autoři: | , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
AME Publishing Company
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7475365/ https://ncbi.nlm.nih.gov/pubmed/32953627 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/gs-20-325 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|